Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6983601 | PMC |
http://dx.doi.org/10.1016/j.aprim.2014.01.003 | DOI Listing |
Aten Primaria
March 2016
Departamento de Economía Aplicada, Facultad de Economía y Empresa, Universidad de Murcia, Murcia, España.
Helicobacter
September 1996
Department of Internal Medicine and Clinical Microbiology, Sint Anna Hospital, Oss, The Netherlands.
Background: Omeprazole enhances the efficacy of bismuth-based triple therapy. It is unknown whether the same is true for other proton pump inhibitors. Lansoprazole has superior anti-Helicobacter activity in vitro and possibly also in vivo; therefore we investigated quadruple therapy with lansoprazole.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!